AccutarBio

About:

AccutarBio employs artificial intelligence to revolutionize drug discovery.

Website: https://www.accutarbio.com

Top Investors: ZhenFund, IDG Capital, Yitu Technology

Description:

AccutarBio employs artificial intelligence to revolutionize drug discovery. AccutarBio's philosophy is to derive a data-driven principle that has the power of explaining physical and chemical nature of biological systems, which we harness to accelerate drug discoveries.

Total Funding Amount:

$76.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2015-01-01

Founders:

Jie Fan, Ke Liu

Number of Employees:

11-50

Last Funding Date:

2021-01-05

IPO Status:

Private

© 2024 MyAiNote.com